2,393 Shares in Elevance Health, Inc. $ELV Bought by 365 WMG Private Fund I Primus Fund LLC

365 WMG Private Fund I Primus Fund LLC acquired a new position in Elevance Health, Inc. (NYSE:ELV) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 2,393 shares of the company’s stock, valued at approximately $930,000.

Other large investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Elevance Health during the second quarter worth $7,344,424,000. State Street Corp lifted its stake in shares of Elevance Health by 1.3% during the second quarter. State Street Corp now owns 10,426,610 shares of the company’s stock valued at $4,032,283,000 after acquiring an additional 137,914 shares during the period. Wellington Management Group LLP lifted its stake in shares of Elevance Health by 12.0% during the second quarter. Wellington Management Group LLP now owns 9,213,513 shares of the company’s stock valued at $3,563,142,000 after acquiring an additional 984,976 shares during the period. First Eagle Investment Management LLC boosted its holdings in Elevance Health by 1.4% in the second quarter. First Eagle Investment Management LLC now owns 4,188,196 shares of the company’s stock valued at $1,619,701,000 after acquiring an additional 55,905 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in Elevance Health in the second quarter valued at about $1,246,349,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Elevance Health Stock Up 2.2%

NYSE:ELV opened at $439.57 on Wednesday. Elevance Health, Inc. has a 12-month low of $274.84 and a 12-month high of $440.67. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $95.33 billion, a P/E ratio of 19.54, a P/E/G ratio of 2.24 and a beta of 0.70. The stock’s fifty day simple moving average is $405.84 and its 200-day simple moving average is $388.57.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $6.99 EPS for the quarter, topping analysts’ consensus estimates of $4.71 by $2.28. The business had revenue of $50.44 billion during the quarter, compared to analysts’ expectations of $49.22 billion. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%. Equities research analysts expect that Elevance Health, Inc. will post 27.20 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ELV. Weiss Ratings reiterated a “hold (c)” rating on shares of Elevance Health in a research report on Thursday, August 13th. Guggenheim upped their target price on shares of Elevance Health from $455.00 to $460.00 and gave the company a “buy” rating in a research report on Monday, October 12th. Wall Street Zen lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Barclays lifted their price target on shares of Elevance Health from $457.00 to $469.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Finally, Raymond James Financial set a $450.00 price target on shares of Elevance Health in a research note on Tuesday, July 7th. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $441.71.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.